Destiny Pharma Limited
Records under this name other than patents Destiny Pharma Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Destiny Pharma Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,084,602 | Porphyrin Derivatives and Their Use in Photodynamic Therapy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,977,474 | Novel Uses of Porphyrin Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 9,326,511 | Methods of Inhibiting Microbial Biofilms Formerly held In force · High confidence | In force | High confidence | |
| US 7,244,841 | Porphyrin Derivatives and Their Use in Photodynamic Therapy Term ended Term ended Dec 23, 2023 · High confidence | Term ended | Term ended Dec 23, 2023 | High confidence |
| US 6,630,128 | Porphyrin derivatives their use in photodynamic therapy and medical devices containing them Lapsed on the fee record Ended Oct 7, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 7, 2015 | From the USPTO record |
| US 6,863,693 | Phospholipid-coated implants Lapsed on the fee record Ended Mar 8, 2009 · From the USPTO record | Lapsed on the fee record | Ended Mar 8, 2009 | From the USPTO record |